---
document_datetime: 2023-09-21 17:25:52
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aranesp-epar-all-authorised-presentations_en.pdf
document_name: aranesp-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 12.7314704
conversion_datetime: 2025-12-26 20:29:36.493249
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration         | Packaging                  | Content             | Package size          |
|-----------------|-----------------|------------|------------------------|---------------------------------|----------------------------|---------------------|-----------------------|
| EU/1/01/185/001 | Aranesp         | 10 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.4 ml (25 µg/ml)   | 1 pre-filled syringe  |
| EU/1/01/185/002 | Aranesp         | 10 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.4 ml (25 µg/ml)   | 4 pre-filled syringes |
| EU/1/01/185/003 | Aranesp         | 15 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.375 ml (40 µg/ml) | 1 pre-filled syringe  |
| EU/1/01/185/004 | Aranesp         | 15 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.375 ml (40 µg/ml) | 4 pre-filled syringes |
| EU/1/01/185/005 | Aranesp         | 20 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.5 ml (40 µg/ml)   | 1 pre-filled syringe  |
| EU/1/01/185/006 | Aranesp         | 20 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.5 ml (40 µg/ml)   | 4 pre-filled syringes |
| EU/1/01/185/007 | Aranesp         | 30 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.3 ml (100 µg/ml)  | 1 pre-filled syringe  |
| EU/1/01/185/008 | Aranesp         | 30 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.3 ml (100 µg/ml)  | 4 pre-filled syringes |
| EU/1/01/185/009 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.4 ml (100 µg/ml)  | 1 pre-filled syringe  |
| EU/1/01/185/010 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.4 ml (100 µg/ml)  | 4 pre-filled syringes |
| EU/1/01/185/011 | Aranesp         | 50 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.5 ml (100 µg/ml)  | 1 pre-filled syringe  |
| EU/1/01/185/012 | Aranesp         | 50 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.5 ml (100 µg/ml)  | 4 pre-filled syringes |
| EU/1/01/185/013 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.3 ml (200 µg/ml)  | 1 pre-filled syringe  |
| EU/1/01/185/014 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.3 ml (200 µg/ml)  | 4 pre-filled syringe  |
| EU/1/01/185/015 | Aranesp         | 80 µg      | Solution for injection | Subcutaneous or                 | pre-filled syringe (glass) | 0.4 ml (200 µg/ml)  | 1 pre-filled syringe  |

intravenous use

<div style=\"page-break-after: always\"></div>

| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration         | Packaging                  | Content             | Package size                       |
|-----------------|-----------------|------------|------------------------|---------------------------------|----------------------------|---------------------|------------------------------------|
| EU/1/01/185/016 | Aranesp         | 80 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.4 ml (200 µg/ml)  | 4 pre-filled syringes              |
| EU/1/01/185/017 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.5 ml (200 µg/ml)  | 1 pre-filled syringe               |
| EU/1/01/185/018 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.5 ml (200 µg/ml)  | 4 pre-filled syringes              |
| EU/1/01/185/019 | Aranesp         | 150 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.3 ml (500 µg/ml)  | 1 pre-filled syringe               |
| EU/1/01/185/020 | Aranesp         | 150 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.3 ml (500 µg/ml)  | 4 pre-filled syringes              |
| EU/1/01/185/021 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.6 ml (500 µg/ml)  | 1 pre-filled syringe               |
| EU/1/01/185/022 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.6 ml (500 µg/ml)  | 4 pre-filled syringes              |
| EU/1/01/185/031 | Aranesp         | 500 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 1 ml (500 µg/ml)    | 1 pre-filled syringe               |
| EU/1/01/185/032 | Aranesp         | 500 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 1 ml (500 µg/ml)    | 4 pre-filled syringes              |
| EU/1/01/185/033 | Aranesp         | 10 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.4 ml (25 µg/ml)   | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/034 | Aranesp         | 15 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.375 ml (40 µg/ml) | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/035 | Aranesp         | 20 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.5 ml (40 µg/ml)   | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/036 | Aranesp         | 30 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.3 ml (100 µg/ml)  | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/037 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.4 ml (100 µg/ml)  | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/038 | Aranesp         | 50 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.5 ml (100 µg/ml)  | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/039 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) | 0.3 ml (200 µg/ml)  | 1 pre-filled syringe (non-blister) |

<div style=\"page-break-after: always\"></div>

| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration         | Packaging                          | Content             | Package size                       |
|-----------------|-----------------|------------|------------------------|---------------------------------|------------------------------------|---------------------|------------------------------------|
| EU/1/01/185/040 | Aranesp         | 80 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass)         | 0.4 ml (200 µg/ml)  | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/041 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass)         | 0.5 ml (200 µg/ml)  | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/042 | Aranesp         | 150 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass)         | 0.3 ml (500 µg/ml)  | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/043 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass)         | 0.6 ml (500 µg/ml)  | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/044 | Aranesp         | 500 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass)         | 1 ml (500 µg/ml)    | 1 pre-filled syringe (non-blister) |
| EU/1/01/185/045 | Aranesp         | 10 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.4 ml (25 µg/ml)   | 1 pre-filled pen                   |
| EU/1/01/185/046 | Aranesp         | 15 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.375 ml (40 µg/ml) | 1 pre-filled pen                   |
| EU/1/01/185/047 | Aranesp         | 20 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.5 ml (40 µg/ml)   | 1 pre-filled pen                   |
| EU/1/01/185/048 | Aranesp         | 30 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.3 ml (100 µg/ml)  | 1 pre-filled pen                   |
| EU/1/01/185/049 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.4 ml (100 µg/ml)  | 1 pre-filled pen                   |
| EU/1/01/185/050 | Aranesp         | 50 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.5 ml (100 µg/ml)  | 1 pre-filled pen                   |
| EU/1/01/185/051 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.3 ml (200 µg/ml)  | 1 pre-filled pen                   |
| EU/1/01/185/052 | Aranesp         | 80 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.4 ml (200 µg/ml)  | 1 pre-filled pen                   |
| EU/1/01/185/053 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.5 ml (200 µg/ml)  | 1 pre-filled pen                   |
| EU/1/01/185/054 | Aranesp         | 150 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.3 ml (500 µg/ml)  | 1 pre-filled pen                   |
| EU/1/01/185/055 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.6 ml (500 µg/ml)  | 1 pre-filled pen                   |

<div style=\"page-break-after: always\"></div>

| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration         | Packaging                          | Content             | Package size                       |
|-----------------|-----------------|------------|------------------------|---------------------------------|------------------------------------|---------------------|------------------------------------|
| EU/1/01/185/056 | Aranesp         | 500 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 1 ml (500 µg/ml)    | 1 pre-filled pen                   |
| EU/1/01/185/057 | Aranesp         | 10 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.4 ml (25 µg/ml)   | 4 pre-filled pens                  |
| EU/1/01/185/058 | Aranesp         | 15 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.375 ml (40 µg/ml) | 4 pre-filled pens                  |
| EU/1/01/185/059 | Aranesp         | 20 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.5 ml (40 µg/ml)   | 4 pre-filled pens                  |
| EU/1/01/185/060 | Aranesp         | 30 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.3 ml (100 µg/ml)  | 4 pre-filled pens                  |
| EU/1/01/185/061 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.4 ml (100 µg/ml)  | 4 pre-filled pens                  |
| EU/1/01/185/062 | Aranesp         | 50 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.5 ml (100 µg/ml)  | 4 pre-filled pens                  |
| EU/1/01/185/063 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.3 ml (200 µg/ml)  | 4 pre-filled pens                  |
| EU/1/01/185/064 | Aranesp         | 80 µg      | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.4 ml (200 µg/ml)  | 4 pre-filled pens                  |
| EU/1/01/185/065 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.5 ml (200 µg/ml)  | 4 pre-filled pens                  |
| EU/1/01/185/066 | Aranesp         | 150 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.3 ml (500 µg/ml)  | 4 pre-filled pens                  |
| EU/1/01/185/067 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 0.6 ml (500 µg/ml)  | 4 pre-filled pens                  |
| EU/1/01/185/068 | Aranesp         | 500 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick) | 1 ml (500 µg/ml)    | 4 pre-filled pens                  |
| EU/1/01/185/069 | Aranesp         | 130 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass)         | 0.65 ml (200 µg/ml) | 1 pre-filled syringe               |
| EU/1/01/185/070 | Aranesp         | 130 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass)         | 0.65 ml (200 µg/ml) | 4 pre-filled syringes              |
| EU/1/01/185/071 | Aranesp         | 130 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass)         | 0.65 ml (200 µg/ml) | 1 pre-filled syringe (non-blister) |

<div style=\"page-break-after: always\"></div>

| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration         | Packaging                                    | Content             | Package size                            |
|-----------------|-----------------|------------|------------------------|---------------------------------|----------------------------------------------|---------------------|-----------------------------------------|
| EU/1/01/185/072 | Aranesp         | 130 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick)           | 0.65 ml (200 µg/ml) | 1 pre-filled pen                        |
| EU/1/01/185/073 | Aranesp         | 130 µg     | Solution for injection | Subcutaneous use                | pre-filled pen (glass) (SureClick)           | 0.65 ml (200 µg/ml) | 4 pre-filled pens                       |
| EU/1/01/185/074 | Aranesp         | 10 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.4 ml (25 µg/ml)   | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/075 | Aranesp         | 10 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.4 ml (25 µg/ml)   | 4 pre-filled syringes with needle guard |
| EU/1/01/185/076 | Aranesp         | 15 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.375 ml (40 µg/ml) | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/077 | Aranesp         | 15 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.375 ml (40 µg/ml) | 4 pre-filled syringes with needle guard |
| EU/1/01/185/078 | Aranesp         | 20 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.5 ml (40 µg/ml)   | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/079 | Aranesp         | 20 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.5 ml (40 µg/ml)   | 4 pre-filled syringes with needle guard |
| EU/1/01/185/080 | Aranesp         | 30 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.3 ml (100 µg/ml)  | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/081 | Aranesp         | 30 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.3 ml (100 µg/ml)  | 4 pre-filled syringes with needle guard |
| EU/1/01/185/082 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.4 ml (100 µg/ml)  | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/083 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.4 ml (100 µg/ml)  | 4 pre-filled syringes with needle guard |
| EU/1/01/185/084 | Aranesp         | 50 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.5 ml (100 µg/ml)  | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/085 | Aranesp         | 50 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.5 ml (100 µg/ml)  | 4 pre-filled syringes with needle guard |
| EU/1/01/185/086 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.3 ml (200 µg/ml)  | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/087 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.3 ml (200 µg/ml)  | 4 pre-filled syringes with needle guard |

<div style=\"page-break-after: always\"></div>

| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of Administration         | Packaging                                    | Content             | Package size                            |
|-----------------|-----------------|------------|------------------------|---------------------------------|----------------------------------------------|---------------------|-----------------------------------------|
| EU/1/01/185/088 | Aranesp         | 80 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.4 ml (200 µg/ml)  | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/089 | Aranesp         | 80 µg      | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.4 ml (200 µg/ml)  | 4 pre-filled syringes with needle guard |
| EU/1/01/185/090 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.5 ml (200 µg/ml)  | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/091 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.5 ml (200 µg/ml)  | 4 pre-filled syringes with needle guard |
| EU/1/01/185/092 | Aranesp         | 130 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.65 ml (200 µg/ml) | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/093 | Aranesp         | 130 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.65 ml (200 µg/ml) | 4 pre-filled syringes with needle guard |
| EU/1/01/185/094 | Aranesp         | 150 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.3 ml (500 µg/ml)  | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/095 | Aranesp         | 150 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.3 ml (500 µg/ml)  | 4 pre-filled syringes with needle guard |
| EU/1/01/185/096 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.6 ml (500 µg/ml)  | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/097 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 0.6 ml (500 µg/ml)  | 4 pre-filled syringes with needle guard |
| EU/1/01/185/098 | Aranesp         | 500 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 1 ml (500 µg/ml)    | 1 pre-filled syringe with needle guard  |
| EU/1/01/185/099 | Aranesp         | 500 µg     | Solution for injection | Subcutaneous or intravenous use | pre-filled syringe (glass) with needle guard | 1 ml (500 µg/ml)    | 4 pre-filled syringes with needle guard |
| EU/1/01/185/100 | Aranesp         | 25 µg      | Solution for injection | Subcutaneous or intravenous use | vial (glass)                                 | 1 ml (25 µg/ml)     | 1 vial                                  |
| EU/1/01/185/101 | Aranesp         | 25 µg      | Solution for injection | Subcutaneous or intravenous use | vial (glass)                                 | 1 ml (25 µg/ml)     | 4 vials                                 |
| EU/1/01/185/102 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous or intravenous use | vial (glass)                                 | 1 ml (40 µg/ml)     | 1 vial                                  |
| EU/1/01/185/103 | Aranesp         | 40 µg      | Solution for injection | Subcutaneous or                 | vial (glass)                                 | 1 ml (40 µg/ml)     | 4 vials                                 |

intravenous use

<div style=\"page-break-after: always\"></div>

| EU Number       | Invented name   | Strength   | Pharmaceutical Form    | Route of                        | Packaging    | Content          | Package size   |
|-----------------|-----------------|------------|------------------------|---------------------------------|--------------|------------------|----------------|
| EU/1/01/185/104 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous or intravenous use | vial (glass) | 1 ml (60 µg/ml)  | 1 vial         |
| EU/1/01/185/105 | Aranesp         | 60 µg      | Solution for injection | Subcutaneous or intravenous use | vial (glass) | 1 ml (60 µg/ml)  | 4 vials        |
| EU/1/01/185/106 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous or intravenous use | vial (glass) | 1 ml (100 µg/ml) | 1 vial         |
| EU/1/01/185/107 | Aranesp         | 100 µg     | Solution for injection | Subcutaneous or intravenous use | vial (glass) | 1 ml (100 µg/ml) | 4 vials        |
| EU/1/01/185/108 | Aranesp         | 200 µg     | Solution for injection | Subcutaneous or intravenous use | vial (glass) | 1 ml (200 µg/ml) | 1 vial         |
| EU/1/01/185/109 | Aranesp         | 200 µg     | Solution for injection | Subcutaneous or intravenous use | vial (glass) | 1 ml (200 µg/ml) | 4 vials        |
| EU/1/01/185/110 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous or intravenous use | vial (glass) | 1 ml (300 µg/ml) | 1 vial         |
| EU/1/01/185/111 | Aranesp         | 300 µg     | Solution for injection | Subcutaneous or                 | vial (glass) | 1 ml (300 µg/ml) | 4 vials        |

intravenous use